Sanofi pasteur (www.sanofipasteur.com) selected BAC’s (www.bac.nl) CaptureSelect® customized affinity ligands for process-scale purification of some of its vaccine products. The platform is manufactured using a high-yielding, yeast-based expression system, which is completely animal-free, BAC states. CaptureSelect ligands thus exploit the nature of camelid single-chain antibody fragments and offer enhanced stability and broad antigen-specific binding compared to traditional affinity media, according to sanofi pasteur.

Next articleUMMZ Periodical Cicada Page